BIIB vs WSBK · P/E 21, rev $9.89B vs P/E 49, rev $42.7M
Biogen Inc (BIIB) versus Winchester Bancorp, Inc. Common Stock (WSBK) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Winchester Bancorp, Inc. Common Stock (WSBK) is a banks - regional company listed on NASDAQ.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported WSBK revenue for 2025-06-30 was $42.7M. Net income was -$874.0K. Revenue was up 22.5% from 2024-06-30 to 2025-06-30. WSBK currently screens at market cap $114.3M and trailing P/E 49.1.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. WSBK currently screens at market cap $114.3M and trailing P/E 49.1.
Not investment advice. Open the BIIB and WSBK stock pages for the full models.
Not investment advice.